ORKA Q3 2024 Earnings — Oruka Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ORKAOruka Therapeutics, Inc.

$1B

Q3 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$29M

Net Income

-$29M

EPS (Diluted)

$-1.91

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$35M

Free Cash Flow

-$35M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$414M

Total Liabilities

$72M

Stockholders' Equity

$342M

Cash & Equivalents

$411M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	-$30,000	+100.0%
Operating Income	-$29M	-$2M	-1420.3%
Net Income	-$29M	-$1M	-1910.0%